Undecane

Undecane

SCHEMBL3628539

CCCCCCCCCCC.O=C(O)C(F)(F)F

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 8/20 0.62
CES1 P23141 5/20 0.62
CES2 O00748 5/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
HSD17B10 Q99714 2/20 0.62
CYP1A2 P05177 1/20 0.62
EPHX1 P07099 1/20 0.56
PPARG P37231 4/20 0.52
PPARD Q03181 4/20 0.52
PPARA Q07869 4/20 0.52
TSHR P16473 3/20 0.52
GPR84 Q9NQS5 3/20 0.52
HDAC11 Q96DB2 3/20 0.52
ALDH1A1 P00352 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
TLR2 O60603 1/20 0.52
ESR1 P03372 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tridecane SCHEMBL27500702 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Decane SCHEMBL3416451 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL28781369 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Dodecane SCHEMBL30416006 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Nonane SCHEMBL4255344 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Heptane SCHEMBL3935940 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Hexadecane SCHEMBL4765353 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Octane SCHEMBL1123657 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Octane SCHEMBL1696265 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A
Heptane SCHEMBL28333176 1.00 FAAH (0.62) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113288892-B Use of poly ADP-ribose polymerase inhibitors against coronaviruses 甫康(上海)健康科技有限责任公司 2024-04-26 CN disclosed
CN-117580830-A Novel pyridine-sulfonamide derivatives as sigma ligands 塔拉森调理公司 2024-02-20 CN disclosed
CN-111793077-B PD-1/PD-L1 small molecule inhibitor and application thereof in medicines 东莞市东阳光新药研发有限公司 2023-08-04 CN disclosed
CN-107849017-B 1,1, 1-trifluoro-3-hydroxypropan-2-ylcarbamate derivatives and 1,1, 1-trifluoro-4-hydroxybutyl-2-ylcarbamate derivatives as MAGL inhibitors 辉瑞公司 2021-03-30 CN disclosed
CN-111793077-A PD-1/PD-L1 small-molecule inhibitor and application thereof in medicines 东莞市东阳光新药研发有限公司 2020-10-20 CN disclosed
CN-107849017-A 1,1, 1-trifluoro-3-hydroxypropan-2-ylcarbamate derivatives and 1,1, 1-trifluoro-4-hydroxybutyl-2-ylcarbamate derivatives as MAG L inhibitors 辉瑞公司 2018-03-27 CN disclosed
CN-106459093-A Alkyl and aryl derivatives of 1-oxa-4, 9-diazaspiro undecane compounds having multimodal anti-pain activity 埃斯蒂文博士实验室股份有限公司 2017-02-22 CN disclosed
CN-104136442-B Pyrans spirocyclic piperidine amide-type as ion channel modulators 沃泰克斯药物股份有限公司 2016-12-21 CN disclosed
CN-101415686-B Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors ANGELETTI P IST RICHERCHE BIO 2013-03-13 CN disclosed
CN-102459268-A Diazahomoadamantane derivatives and methods of use thereof ABBOTT LAB 2012-05-16 CN disclosed
CN-102007108-A Inhibitors of chemokine receptor CxCR3 SANOFI AVENTIS 2011-04-06 CN disclosed
WO-2010151815-A2 3,9-DIAZASPIRO[5,5]UNDECANE AMIDES AND UREAS AND METHODS OF USE THEREOF ABBOTT LABORATORIES (US) 2010-12-29 WO disclosed
CN-101415686-A Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors ANGELETTI P IST RICHERCHE BIO (IT) 2009-04-22 CN disclosed
CN-101305005-A Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases ASTRAZENECA AB (SE) 2008-11-12 CN disclosed
EP-1926730-A1 NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES AstraZeneca AB (SE) 2008-06-04 EP disclosed
WO-2007030061-A1 NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES ASTRAZENECA AB (SE) 2007-03-15 WO disclosed
CN-1898239-A Novel diazaspiroalkanes and their use in the treatment of CCR8 mediated diseases ASTRAZENECA AB (SE) 2007-01-17 CN disclosed